# FDA Inspection 1166333 - Primary Children's Hospital - March 10, 2022

Source: https://www.keypedia.com/records/fda_inspections/primary-childrens-hospital/2837466d-1a98-43c7-af02-1dda2ee5c245
Source feed: FDA_Inspections

> FDA Inspection 1166333 for Primary Children's Hospital on March 10, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166333
- Company Name: Primary Children's Hospital
- Inspection Date: 2022-03-10
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1267113 - 2025-04-17](https://www.keypedia.com/records/fda_inspections/primary-childrens-hospital/a035fda3-0bcc-42fe-8611-cb598d75f36e)
- [FDA Inspection 1166333 - 2022-03-10](https://www.keypedia.com/records/fda_inspections/primary-childrens-hospital/af829fa9-ab3c-4190-a782-07f702d69088)

Company: https://www.keypedia.com/companies/primary-childrens-hospital/c5e47623-6dfa-48f9-9719-c1e2a1fd1585

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d